Thank you.
This question is for anyone who would like to answer it. In his spring 2013 report, the Auditor General said this:
The success of the Canadian Diabetes Strategy depends on partnerships that are only partially in place. The Agency established a forum to get advice from diabetes experts, but it has not functioned as intended. A committee established to coordinate activities within the federal health portfolio is no longer active. For example, the Agency aims to deliver evidence-based diabetes policies and programs, but it has established no mechanism for collaborating regularly with the Canadian Institutes of Health Research on its research needs. As a result, federal diabetes activities are fragmented, and the impact of efforts and money spent has not been maximized.
Has anything improved in the last five years since 2013? Do you have any advice to give us as a federal committee as to how we could address those concerns?